Pacific Edge is planning to open its first US franchise to
market bladder cancer detection test, Cxbladder(R), by the end of
the year.
The New Zealand business is joining Pennsylvania research
facility Hershey Center for Applied Research (HCAR),
and intends to set up shop next to its technology suites.
The project will open in August and
provide state-subsidised lab and office suites for technology
companies.
The Pacific Edge facility will serve as an office and processing
facility for analysis of the Cxbladder(R) test, which uses the
genes in a patient's urine to detect the presence of bladder
cancer.
The launch of the franchise also calls for approximately 100
people to be hired in Pennsylvania over the next three years.
--Idealog--
Read full article
